Development of selective amplifier genes for hematopoietic stem cell gene therapy
β Scribed by Keiya Ozawa; Yutaka Hanazono; Akihiro Kume; Takeyuki Nagashima; Yasuji Veda; Keiji Terao; Mamoru Hasegawa
- Publisher
- Carden Jennings Publishing
- Year
- 2002
- Tongue
- English
- Weight
- 216 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Hematopoietic stemβcellβdirected gene transfer has achieved limited success in transducing clinically relevant levels of target cells. The expansion of geneβmodified cells is one way to circumvent the problem of inefficient transduction with current vectors. To this end,
Hematopoietic stem cell gene therapy is potentially curative for a number of inherited and acquired disorders. However, poor gene transfer and expression in repopulating hematopoietic stem cells attenuate this potential. Here we review potential means of conferring a selective advantage to hematopoi
From the time that the genes encoding the defective proteins were cloned for a number of inherited diseases, it became a goal to correct those conditions by restoring the normal gene and thereby, its product. For the inherited disorders affecting the blood and its progenitor cells, the hematopoietic